Hospital Universitario Doce de Octubre

Madrid 28041

0 studies enrolling now · 9 studies all time

What they study most

Advanced Malignancies, Anemia, Bleeding Disorder, Clostridium Difficile, Coagulation Disorder, Coronary Artery Disease, HER2-amplified Biliary Tract Cancers, HIV Infection, HRAS Mutant Tumor, Heart Failure, Hematological Diseases, Hemorrhagic Stroke

Studies at this site

• A Study of Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung Cancer — Stopped early
• A Study of ZW25 (Zanidatamab) in Subjects With Advanced or Metastatic HER2-Amplified Biliary Tract Cancers — Completed
• Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies — Completed
• Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS Mutations — Completed
• Strategic Timing of Antiretroviral Treatment — Completed
• Telomere Associated Variables (TAVs) in Prostate Cancer — Completed
• MOre REsponse on Cardiac Resynchronization Therapy With MultiPoint Pacing — Stopped early
• XIENCE 28 USA Study — Completed
• Observational Study of C. Diff in Post-Transplant Patients — Completed